Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-04Clinical Trial Update: Phase I Study of Safety and Feasibility of Transarterial Embolization of Incurable Hypervascular Pediatric Soft Tissue Sarcomas [NA]
A Phase I study evaluating the safety and feasibility of transarterial embolization for incurable hypervascular pediatric soft tissue sarcom…
-
CLINICAL_TRIALS withdrawal · 2025-12-01Clinical Trial Update: Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab with or without olaparib in TLS-positive selected resectable soft tissue sarcoma, followed…
-
CLINICAL_TRIALS withdrawal · 2025-11-21Clinical Trial Update: A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating BT-001 alone and in combination with pembrolizumab in metastatic or advanced solid tumors has been terminated.
-
CLINICAL_TRIALS withdrawal · 2025-09-02Clinical Trial Update: Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures [Phase 2]
Phase 2 trial targeting MDMD and PD-1 in tumors with tertiary lymphoid structures has been withdrawn; the study covered soft tissue sarcoma,…
-
CLINICAL_TRIALS withdrawal · 2025-08-26Clinical Trial Update: Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma [Phase 1]
Phase 1 study evaluating propranolol with standard radiation therapy before surgery for soft tissue sarcoma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-02-24Clinical Trial Update: A Phase 2 Study Using Aliya PEF Plus Pembro for Sarcoma [Phase 2]
Phase 2 study of Aliya PEF Plus pembrolizumab for soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-01-01Clinical Trial Update: A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors [Phase 2]
A Phase 2 pilot study evaluating Thermodox in combination with MR-HIFU for relapsed solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-18Clinical Trial Update: Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas [Phase 1, Phase 2]
Phase 1/2 trial of neoadjuvant lurbinectedin with preoperative radiation for locally advanced soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer [Phase 1]
A Phase 1 trial investigating TAS-116 in combination with palbociclib for advanced breast cancer and RB-deficient solid tumors has been with…
-
CLINICAL_TRIALS withdrawal · 2024-08-15Clinical Trial Update: Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES) [Phase 1]
Phase 1 trial FLARES investigating fluorescence-guided resection for soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-07-17Clinical Trial Update: Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma [Phase 3]
A Phase 3 trial (Brightline-3) testing brigimadlin in combination with ezabenlimab for advanced soft tissue sarcoma, including undifferentia…
-
CLINICAL_TRIALS withdrawal · 2024-05-16Clinical Trial Update: Camsirubicin + Pegfilgrastim to Determine MTD in ASTS [Phase 1]
Phase 1 trial of Camsirubicin plus Pegfilgrastim to determine the maximum tolerated dose in advanced soft-tissue sarcoma has been terminated…
-
CLINICAL_TRIALS withdrawal · 2020-05-19Clinical Trial Update: Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma [Phase 2, Phase 3]
Phase 2/3 trial comparing pegylated liposomal doxorubicin to pirarubicin plus ifosfamide and dacarbazine for locally advanced, unresectable,…
-
CLINICAL_TRIALS withdrawal · 2017-10-10Clinical Trial Update: A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment
This clinical trial update states that the NCT00210665 study of trabectedin for locally advanced or metastatic soft tissue sarcoma is no lon…
-
CLINICAL_TRIALS withdrawal · 2017-08-22Clinical Trial Update: Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas [Phase 2]
A Phase 2 study evaluating nivolumab with or without pazopanib in metastatic or unresectable soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-10Clinical Trial Update: Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas [Phase 2]
The Phase 2 trial of proton chemoradiotherapy for high-risk soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-12Clinical Trial Update: Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating pazopanib as maintenance therapy for advanced soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-26Clinical Trial Update: Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery [Phase 1]
The Phase 1 safety study of BLZ-100 in adults with soft tissue sarcoma undergoing surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-03Clinical Trial Update: NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma [Phase 1]
Phase 1 trial of NY-ESO-1–specific T cells after cyclophosphamide for advanced synovial sarcoma or myxoid liposarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-23Clinical Trial Update: Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma [NA]
A clinical trial evaluating isolated limb perfusion with melphalan for stage IIIB-IV melanoma or soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-06-27Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma [Phase 2]
A Phase 2 trial evaluating combination chemotherapy, radiation therapy, and surgery for primary or recurrent soft tissue sarcoma has been wi…
-
CLINICAL_TRIALS withdrawal · 2012-08-01Clinical Trial Update: Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients
A clinical trial studying functional outcomes after limb-sparing surgery for sarcoma patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-12Clinical Trial Update: Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma [Phase 1]
A Phase 1 study of ridaforolimus in combination with standard chemotherapy for soft tissue sarcoma has been withdrawn.